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RESEARCH ARTICLE Open Access
Diabetes conversation map - a novel tool
for diabetes management self-efficacy
among type 2 diabetes patients in Pakistan:
a randomized controlled trial
Rubina Qasim1,2*† , Sarfaraz Masih1, Mohammad Tahir Yousafzai3†, Hakim shah2, Abdul Manan4, Yousaf Shah1,
Muhammad Yaqoob1, Abida Razzaq5, Ajmal Khan1 and Atiya Rahman Khan Rohilla2
Abstract
Background: This study aimed to measure the effect of diabetes education using the novel method of “diabetes
conversation map (DCM)” as compared to routine counselling (RC) on diabetes management self-efficacy (DMSE)
among patients living with type 2 diabetes in Karachi, Pakistan.
Methods: A parallel arm randomized controlled trial among patients with type 2 diabetes aged 30–60 years, with
HbA1c > 7%, diagnosed for at least 5 yrs., was conducted at the national institute of diabetes and endocrinology in
Karachi, Pakistan. A total 123 type 2 diabetes patients were randomized into DCM (n = 62) or RC (n = 61). Four
weekly diabetes control sessions of 40 min each using the DCM or RC was provided. DMSE was measured using a
validated Urdu language DMSE tool at baseline and after three months of the randomization. Change in DMSE and
HbA1c levels within groups (pre-post) and between the groups after 3 months of enrollment was compared.
Results: Baseline characteristics except HbA1c were similar between the two arms. After 3 months of enrollment,
there was no change in the DMSE score in the RC arm however, significant increase in DMSE score was noted in
the DCM arm (P = < 0.001). The average difference (95% confidence interval) in DMSE score between the DCM and
RC arm was 33.7(27.3, 40.0; p = < 0.001) after 3 months of the enrollment. Difference in HbA1c within groups was
not significant.
Conclusions: DCM significantly improved DMSE among type 2 diabetes patients in a developing country setting
like Pakistan. Healthcare workers caring for type 2 diabetes patients need to be trained on DCM to effectively utilize
this novel tool for educating diabetes patients.
Trial registration: This trial was prospectively registered. ClinicalTrials.gov Identifier: NCT03747471. Date of
registration: Nov 20. 2018.
Keywords: Diabetes management, DMSE, Diabetes mellitus type 2, Conversation map, Diabetes education,
Diabetes management self-efficacy, Pakistan, Lower middle-income countries
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Background
The world has observed more than four times increase
in the number of cases of adult diabetes during the last
four decades. The number of adult diabetes cases in-
creased from 108 million in 1980 to 463 million in 2019
and the projections for 2045 is about 700 million [1, 2].
Globally, about a third of the diabetes burden is in the
low middle income countries (LMIC). Pakistan being a
LMIC, also experienced an increase from 1.7 million of
adult diabetes patients in 1980 to 19.4 million in 2019
and is considered as one of the top 10 countries with
highest number of adult population living with diabetes
(diabetes prevalence of ≥12%).(1; 2) In 2019, about 4.2
million deaths attributed to diabetes and diabetes related
complications occurred globally and almost half (46.2%)
of the deaths (majority from lower middle income coun-
tries) were among the working age group (< 60 years
old) [2, 3]. According to the sustainable development
goals (SDG), by 2030 the premature deaths attributed to
non-communicable diseases should be reduced by 1/3rd
globally [4]. Since the life style habits including daily
routine are associated with diabetes and its control,
therefore people living with diabetes can play an import-
ant role in their disease management [5].
Diabetes management self-efficacy (DMSE)
Self-efficacy (SE) is considered as an essential pre-
requisite for the initiation and adoption of healthy life-
style habits [6, 7]. In 1977, Albert Bandura described SE
as one’s ability to influence or perform actions that af-
fects life and to exercise control over these actions. Also,
Bandura proposed that people take actions when they
believe they can do it and hesitate to take actions when
they do not believe they can be able to perform [8]. Sev-
eral studies have reported the association between self-
efficacy and diabetes management, blood glucose levels,
quality of life and eating behaviors among people living
with diabetes [9–12]. Thus, self-efficacy is considered as
an important factor which can play an important role in
the management of diabetes mellitus.
Diabetic conversation map (DCM)
The orthodox methods of teaching people with diabetes
to control their disease, prevent complications, and im-
prove quality of life, are predominantly through didactic
lectures, brochures, pamphlets, and routine counselling
[13, 14]. While these methods have shown some benefit
in terms of diabetes control among patients, studies have
reported level of education among patients as one of the
important predictor for these benefits [15–17]. Among
novel methods, Diabetes Conversation Maps (DCM) are
considered as useful tools for the education of diabetes
patients [18]. DCM are interactive tools containing pic-
torial messages and directions designed to educate
patients with diabetes and their family members. Since
the messages are predominantly self-explanatory
depicted in pictures, it does not need formal education.
In LMIC like Pakistan with a less than 50% literacy rate,
these tools might prove to be effective for the control of
diabetes and its associated complications [19].
DCM have already been tested in several countries
across the world [20, 21]. In the developing world, it has
shown some impact through observational studies how-
ever, literature generated from randomized control trials
is limited [22, 23]. Factors such as formal education, ac-
cess to the modern modes of communication (internet,
social media), sociodemographic characteristics and en-
vironmental exposures are different in the LMIC as
compared to the first world countries and hence there is
a need to test the effectiveness of DCM in the develop-
ing world context. Therefore, this study aimed to meas-
ure the effectiveness of DCM versus routine counselling
(RC) to improve DMSE among patients living with type
2 diabetes in LMIC setting like Karachi, Pakistan.
Methods
Detail methodology of the study is available in the pub-
lished study protocol [24].
Design, setting and randomization
This was two 1:1 parallel arm unblinded randomized
controlled trial conducted during November 26, 2018 to
May 30, 2019. The study was conducted at National In-
stitute of Diabetes and Endocrinology (NIDE), Dow Uni-
versity of Health Sciences, Karachi, Pakistan. NIDE is
one of the largest public sector diabetes centers located
in the heart of the metropolitan city of Karachi, Pakistan.
The center provides outpatient, inpatient, and diagnostic
facilities at subsidized rates to all diabetes patients of Ka-
rachi and other parts of Sindh province (Southern
Pakistan). The daily turnover (Monday to Saturday) in
the outpatient department is more than 200 diabetes pa-
tients. A unique computerized medical record number is
provided to every patient visiting the hospital for the
first time. All the medical records including record of la-
boratory investigations being performed at the hospital
are archived using the unique medical record number.
The individual randomization was performed by the
one of the investigators (MTY) through the generation
of random digit numbers from 1 to 120 using Microsoft
excel 10 (RANDBETWEEN function). Random digit
numbers ≤60 was assigned to the DCM arm and num-
bers above 60 were assigned to the RC arm. Random
digit numbers with corresponding assignments were
sealed in the opaque envelops by MTY, kept in sequence
and the other investigator (RQ) opened the envelops
consecutively as patients were screened and found eli-
gible for enrollment into the study.
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Population and sample size
The inclusion criteria for enrollment of patients was aged
30–60 years, visiting outpatient department of NIDE,
already diagnosed with type 2 diabetes for ≥5 years,
HbA1c levels> 7%, and positive for diabetes distress (DD)
using the validated DD screening tool [25]. Patients with
type 2 diabetes suffering from major disabilities, mental
illness, severe complications related to diabetes, and living
outside Karachi were excluded from this study.
The sample size for this trial was calculated for two
different objectives. Objective 1 related to the impact of
DCM on DMSE and objective 2 related to the impact of
DCM on DD. While the sample size calculation for both
the objectives is provided here, data from objective 2 is
not included in this manuscript. The sample size for ob-
jective 1 was estimated based on the findings from a ran-
domized controlled trial conducted among patients with
type 2 diabetes in rural Thailand [26]. The study tested
the effectiveness of family oriented diabetes self-
management education versus routine care to improve
diabetes management self-efficacy (DMSE) using the val-
idated DMSE scale [27]. The study reported average ±
standard deviation DMSE scores of 55.6 ± 12 at baseline
which increased to 76 ± 9.4 after 13 weeks of enrollment
in the intervention arm and 58.7 ± 11.4 which increased
to 60.7 ± 13.1 in the control arm. DMSE scores at base-
line were similar between the two groups, however at 13
weeks the difference between the two scores was highly
significant (p = < 0.001). Considering the difference of 15
in the average DMSE scores [26] between the DCM and
RC after 3 months of randomization, assuming 95% con-
fidence level, 90% power to detect the given difference in
two arms, adjustment for 10% attrition rate, the mini-
mum sample size for objective 1 was N = 40 (20 patients
in each arm). For objective 2, the sample size was esti-
mated based on a pilot randomized controlled trial con-
ducted in China [28]. The study reported average ±
standard deviation score of DD (DD measured through a
validated screening tool [25]) between control and inter-
vention group at baseline as 32.77 ± 14.57 and 26.08 ±
9.92 respectively (p value = 0.073). After 6 months of the
intervention the respective scores were 30.09 ± 12.14 and
22.79 ± 4.95 (p value = 0.014) between the two groups,
respectively. Considering a higher average difference of
the differences (difference of 7.30) as compared to the
study from china (difference of 0.62) [28] between the
two arms (which is also clinically significant), assuming
95% confidence level and 80% power to detect the given
difference, the minimum sample size to achieve the ob-
jective 2 was N = 88 (44 in each group). After adding at-
trition rate of 30%, a total of 120 participants (60 in each
arm) were needed. Since the sample size for objective 2
was higher than the sample size for objective 1, hence it
was used for enrollment in this study.
Operational definitions
Diabetes control: Patients with type 2 diabetes with gly-
cated hemoglobin A1c (HbA1c) ≤7% were considered
with a controlled diabetes.
Suboptimal control of diabetes: Patients with type 2
diabetes with HbA1c more than 7% were considered
with suboptimal control of diabetes.
Enrollment and data collection procedure
Detailed enrollment and data collection procedure is
provided in the published protocol of this study [24].
After necessary screening for eligibility and seeking writ-
ten informed consent for participation, eligible partici-
pants were enrolled and randomized into the two arms.
We used a structured pilot tested questionnaire devel-
oped in English, translated into Urdu and back trans-
lated to English for the data collection. Data was
collected through face-to-face interview by the Principal
Investigator (RQ) of this project. Clinical, laboratory and
latest anthropometric data such as treatment, comorbid-
ities, any complications, HbA1c, any other laboratory
tests being performed recently, height and weight were
retrieved from the respective medical record file. The
same questionnaire was used for the follow-up data col-
lection after 3 months of the randomization. English ver-
sion of the questionnaire is already published [24].
The DMSE was measured using validated Urdu ver-
sion of the DMSE scale [27]. The scale has 20 Likert
items, each with response ranging from 0 to 10 (0 =
completely unable, 10 = completely able). DMSE scale
total possible score ranges from 0 to 200, with higher
score representing higher diabetes management self-
efficacy. Internal consistency of the scale based on data
from this study was satisfactory (Cronbach’s alpha =
0.96). Factor analysis of the DMSE scale based on our
data revealed four different dimensions measured by the
scale; 1) exercise and weight control, 2) diabetic treat-
ment, 3) blood glucose monitoring, and 4) diet control.
There were 10 Likert items in the DMSE sub-scale re-
lated to exercise and weight control with the score range
0–100. In the sub-scale related to diabetes treatment,
there were 5 Likert items with score range from 0 to 50.
Similarly, in the sub-scales related to blood glucose
monitoring and diet control, there were 3 and 2 Likert
items respectively with the score range from 0 to 30 and
0–20 respectively. Further details on validation and reli-
ability assessment of the DMSE scale are beyond the
scope of this paper and will be published later.
Intervention and follow-ups
Participants in the DCM arm received 4 education ses-
sions each (in groups of 6–8 participants) of 40 min dur-
ation using the standard pictorial colorful conversation
maps [18]. The pictorial maps addressed issues related
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to managing diabetes, healthy lifestyle, starting insulin,
and experiencing life with diabetes. There were four dif-
ferent DCM tools, each with a specific domain related to
diabetes self-management such as 1) living with diabetes,
2) how diabetes works, 3) healthy eating and keeping ac-
tive, and 4) starting insulin. (Additional file 1, DCM
maps adopted from healthy interactions catalog and
translated in Urdu by Lilly pharmaceuticals Pvt. Ltd.
Pakistan. Permission for use and publication obtained
from Lilly Pakistan Ltd. which is a partner of Healthy In-
teractions LLC 311W. Superior St. Chicago, IL USA.).
Participants in the RC attended 4 routine diabetes coun-
seling provided by the diabetes clinics’ trained nurses. The
counselling sessions were provided in groups of 6–8 and
each session ranged from 30 to 40min. The sessions in
both DCM and RC arms were organized on weekly basis,
started immediately after randomization. (Table 1) Separ-
ate counselling room located in the same building of the
consultant clinics was used for teaching the participants in
the DCM arm while the participants in RC arm received
counselling as usual in the outpatient department area.
Statistical analysis
Data was entered into statistical package for social scien-
tists (SPSS) version 25 (IBM®). Intention to treat analysis
was performed. Data cleaned and any discrepancies or
missing information were validated against the physical
questionnaires and/or medical record files. Body mass
index (BMI) was computed using the formula weight in
kilogram/(height in meters)2 and classified into three
categories based on recommendations of WHO expert
consultation for BMI categories for Asian population for
public health action. BMI 18.5 to < 23 was categorized
as acceptable risk, 23 to 27.5 as increased risk and ≥ 27.5
as high risk [29]. Variables containing sum of scores for
DMSE, and its sub-scales (factors) were computed by
adding the respective Likert scale items. Assumptions
for parametric tests especially normality and
Table 1 Checklist for the schedule of enrolment, interventions, and assessments
DMSE Diabetes management self-efficacy
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homogeneity of variance were tested for all continuous
scale variables. Descriptive analysis was performed by
using frequency with percentages for all categorical vari-
ables and mean with standard deviations for all continu-
ous scale variables. The distribution of all variables
including independent (demographic, anthropometric,
lifestyle habits and clinical characteristics) and
dependent (DMSE and its sub-scales) were compared at
baseline between the intervention (DCM) and control
(RC) arms. P values were calculated using Pearson Chi
Square test for categorical and independent sample T
test for the continuous scale variables. Data on DMSE,
DMSE sub-scales and HbA1c at 3 months following the
randomization were compared using the independent
sample T test. Differences with P values of less than 0.05
were considered significant.
Results
We approached 620 type 2 diabetes patients and 123/
620(19.8%) were eligible for enrollment. Out of 123
participants, 61(49.6%) were randomized into the RC
and 62(50.4%) were randomized into the DCM arms.
Among total randomized into the two arms, only 58/
61(95%) received routine counselling and also provided
baseline data in the RC arm and only 54/62(87%) re-
ceived education based on conversation map and pro-
vided baseline data in the DCM arm. There was n = 3
and n = 8 patients in the RC and DCM arm respectively
who withdrew their consent after randomization and did
not provide baseline data. There was no loss to follow-
up in the subsequent four visits. Figure 1 is a consort
diagram showing the flow of the patients in both arms.
At baseline, there was no significant difference in
terms of age, gender, monthly income, level of educa-
tion, and marital status between the two arms. Overall,
about 75% of the participants were 45–60 years old.
About half of the participants were female with a slightly
higher proportion in the DCM arm (57%) as compared
to the RC arm (45%) however the difference was not sta-
tistically significant (p value 0.183). Similarly, at baseline,
Fig. 1 Consort diagram showing the number of participants at enrollment and follow-ups
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lifestyle habits e.g. activity pattern, smoking status, sub-
stance abuse and body mass index (BMI) were similar
between the two arms. Overall, slightly less than half
(40%) of the participants in this study were high risk
(BMI > 27.5). (Table 2).
At baseline, average score of DMSE and DMSE sub-
scales, history of diabetes, and co-morbidities were simi-
lar between the two arms. However, participants in the
RC arm had average HbA1C level of 10 ± 1.8 as com-
pared to 9.0 ± 1.5 in the DCM arm (p value = 0.042).
Similarly, current diabetes treatment was statistically dif-
ferent between the two arms. About a quarter (28%) of
the participants in the DCM arm were receiving insulin
as compared to 16% of the participants in RC arm and
67% of the participants receiving oral hypoglycemic
drugs in the RC arm as compared to 43% in DCM arm
(P value 0.032). (Table 3).
While there was no statistically significant difference
in DMSE score at the baseline, at 3 months follow-up
the average difference in DMSE score (95% confidence
interval) increased to 33.7(27.3, 40.0) between the DCM
and RC arm (p value = < 0.001). Besides, there was no
significant difference in average scores of the DMSE
sub-scales between the two arms at the baseline how-
ever, after 3 months the average score of DMSE in DCM
arm increased significantly as compared to the RC arm.
Table 2 Comparison of baseline sociodemographic, lifestyle and anthropometric data the two arms (N = 112)
Total DCM RC
Sociodemographic N = 112(%) n = 54(%) n = 58(%) P value
Age groups (Yrs)
30 - < 45 28 (25) 14 (25.9) 14 (24.1) 0.827
45–60 84 (75.0) 40 (74.1) 44 (75.9)
Gender
Male 55 (49.1) 23 (42.6) 32 (55.2) 0.183
Female 57 (50.9) 31 (57.4) 26 (44.8)
Monthly income (PKR)
≤ 25,000 20 (17.9) 8 (14.8) 12 (20.7) 0.704
26,000–50,000 41 (36.6) 20 (37.0) 21 (36.2)
> 50,000 51 (45.5) 26 (48.1) 25 (43.1)
Education level
≤ Secondary 65 (58.0) 27 (50.0) 38 (65.5) 0.096
> Secondary 47 (42.0) 27 (50.0) 20 (34.5)
Marital status
Single/widow/divorce 4 (3.6) 4 (7.4) 0 0.051
Married 108 (96.4) 50 (92.6) 58 (100)
Activity pattern
Active 77 (68.8) 36 (66.7) 41 (70.7) 0.646
Sedentary 35 (31.3) 18 (33.3) 17 (29.3)
Smoking
Yes 9 (8.0) 3 (5.6) 6 (10.3) 0.492
No 103 (92.0) 51 (94.4) 52 (89.7)
Substance abuse
Yes 11 (9.8) 4 (7.4) 7 (12.1) 0.407
No 101 (90.2) 50 (92.6) 51 (87.9)
BMI (kg/m2) based on cut-off points for public health action in Asian population
(Increasing but acceptable risk) 18.5- < 23 24 (21.8) 15 (28.3) 9 (15.8) 0.275
(Increased risk) 23–27.5 42 (38.2) 18 (34.0) 24 (42.1)
(High risk) > 27.5 44 (40.0) 20 (37.7) 24 (42.1)
DCM Diabetes Conversation Map (Intervention arm), RC Routine care (Control arm)
P values are two sided calculated based on Pearson chi-square or fisher exact test for the categorical variables and independent samples t test for the
continuous variables
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While the difference in average HbA1c level between the
DCM and RC arms was statistically significant at both
baseline and 3months follow up, the reduction in
HbA1c within the groups (pre-post) in both the DCM
and RC arms was not statistically significant to achieve
diabetes control (HbA1c < 7%) in any of the two groups.
This should be noted that treatment regimen remained
same during the study period in both the groups while 1
unit decline in HbA1c was noticed in both RC and
DCM arm. (Table 4).
Discussion
This study is first in the region evaluating the effective-
ness of DCM against RC to improve DMSE. In this
study four education sessions on diabetes using DCM as
compared to RC significantly improved the DMSE score.
Similarly, this study also observed significant improve-
ment in the DMSE sub scales (Exercise and weight con-
trol, health seeking and diabetes treatment, blood sugar
monitoring, and diet control) in the DCM arm as com-
pared to the RC arm. In this study, significant difference
was observed in HbA1c between DCM and RC arms
however, the difference in HbA1c levels within each arm
(post-pre) was not statistically significant.
We could not find any other study evaluating the ef-
fect of DCM on DMSE however, several studies from
different countries including Pakistan has assessed the
impact of DCM on other outcomes among patients with
diabetes mellitus. A randomized controlled pilot trial in
China studied the effect of DCM as compared to
Table 3 Comparison of baseline clinical characteristics, DMSE and sub-factors of DMSE between intervention and control arms (N =
112)
Total DCM RC
Clinical characteristics N = 112(%) n = 54(%) n = 58(%) P value
Family history of diabetes
Yes 85 (75.9) 41 (75.9) 44 (75.9) 0.994
No 27 (24.1) 13 (24.1) 14 (24.1)
Duration of diagnosis of diabetes (Mean ± SD yrs) 9.5 ± 5.8 10.2 ± 6.3 8.8 ± 5.3 0.209
HbA1c at baseline (Mean ± SD) 9.3 ± 1.7 9.0 ± 1.5 10.0 ± 1.8 0.042
Comorbidities
Hypertension 48 (92.3) 25 (92.6) 23 (92.0) 0.936
Other (CHD, COPD) 4 (7.7) 2 (7.4) 2 (8.0)
No information – –
Treatment
Insulin 24 (21.4) 15 (27.8) 9 (15.5) 0.032
Oral 62 (55.4) 23 (42.6) 39 (67.2)
both 26 (23.2) 16 (29.6) 10 (17.9)
Ovrall DMSE at baseline (Mean ± SD) 81.7 ± 17.2 81.6 ± 16.9 81.8 ± 17.4 0.938
Factor 1:DMSE exercise & weight control (Mean ± SD) 36.5 ± 10.3 35.3 ± 9.8 37.6 ± 10.8 0.241
Factor 2: Health seeking and diabetes treatment (Mean ± SD) 29.5 ± 7.1 30.6 ± 7.3 28.4 ± 6.8 0.112
Factor 3:Blood sugar monitoring (Mean ± SD) 11.2 ± 2.7 11.1 ± 2.7 11.2 ± 2.7 0.72
Factor 4:Diet control (Mean ± SD) 4.5 ± 1.9 4.6 ± 2.0 4.5 ± 1.7 0.798
DCM Diabetes Conversation Map (Intervention arm), RC Routine care (Control arm)
P values are two sided calculated based on Pearson chi-square or fisher exact test for the categorical variables and independent samples t test for the
continuous variables
Table 4 Comparison of diabetes management self-efficacy, and HbA1c after 3 months of enrolment (N = 112)
Clinical characteristics DCM RC Difference(95%CI) P value
Overall DMSE score after 3 months of enrolment (Mean ± SD) 115.5 ± 18.0 81.9 ± 15.8 33.7 (27.3,40.0) < 0.001
Factor 1:Exercise & weight control (Mean ± SD) 56.2 ± 10.5 37.1 ± 9.1 19.0 (15.3,22.7) < 0.001
Factor 2: Health seeking and diabetes treatment (Mean ± SD) 36.1 ± 4.9 28.3 ± 5.6 7.9 (5.8,9.8) < 0.001
Factor 3:Blood sugar monitoring (Mean ± SD) 16.6 ± 3.1 11.7 ± 2.8 4.8 (3.7,5.9) < 0.001
Factor 4:Diet control (Mean ± SD) 6.6 ± 2.3 4.6 ± 2.2 1.9 (1.1,2.8) < 0.001
HbA1c post intervention (Mean ± SD) 8.2 ± 1.4 9.1 ± 1.8 −0.92(−1.68, −0.16) 0.025
DCM Diabetes Conversation Map (Intervention arm), RC Routine care (Control arm)
P values are two sided calculated based on independent sample t test between intervention and control arm
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traditional education on diabetes distress and diabetes
empowerment among patients with type 2 diabetes mel-
litus. They observed significant increase in the diabetes
empowerment score at 6 months following enrollment
in the intervention arm as compared to the control [28].
While the study in China reported the effectiveness of
DCM to improve empowerment among diabetes pa-
tients, their outcome (diabetes empowerment) was not
similar to our outcome (DMSE) and hence cannot be
compared. Besides, the sample size in Chinese study was
only 53 as compared to our study where the number of
participants was more than doubled. Similarly, in Chin-
ese study the last follow up was 6 months after the en-
rollment as compared to our study where the last follow
up for measurement was only 3 months after the enroll-
ment. Another randomized controlled trial conducted
among patients with type 2 diabetes mellitus found sig-
nificant impact of DCM as compared to the routine care
on patients’ satisfaction with care, perception of goal at-
tainment and knowledge of diabetes after 6 months of
the intervention [30].
A cross sectional study conducted at a tertiary care
hospital in Karachi Pakistan where diabetic education
was provided through DCM found significant improve-
ment in knowledge, attitude and practices of the patients
with type 2 diabetes mellitus [23]. Unlike these studies, a
recently conducted systematic review which aimed to
generate evidence regarding the effect of DCM on the
behavior related to drug adherence, level of HbA1c and
blood pressure control, reported inconclusive evidence.
The authors of the systematic review concluded that
DCM has the potential to positively affect the behavior
and health outcome of type 2 diabetes patients however,
sufficiently powered, well designed studies are recom-
mended to fill the existing knowledge gap [31].
In this study, we could not find the significant impact
of DCM on HbA1c, however 1unit decline in HbA1c
was noted in both RC and DCM arms as compared to
the baseline HbA1c while the antidiabetic treatment was
not changed during the study duration. This finding is
consistent with another study from Spain where DCM
as compared to routine care was found to be signifi-
cantly associated with improvement in knowledge how-
ever, no impact on clinical outcomes including HbA1c
[30]. There could be several reasons for the lack of asso-
ciation between DCM and improvement in HbA1c.
Firstly, HbA1c is an indicator of long term glycemic
control indicating the cumulative glycemic history for
the last 2–3 months [32]. Since, we measured the change
in HbA1c only after 3 months of the enrollment and
during the initial 1 month, 4 weekly sessions were con-
ducted thus the time to bring change in the daily rou-
tines, behaviors, practices based on the education
resulting in improvement of HbA1c might not be
sufficient. Secondly, studies in the past have reported
that improvement in the HbA1c level is relatively diffi-
cult among diabetes patients with longer duration of the
illness as compared to the patients who are newly diag-
nosed [33]. Since the average of duration of illness in
this study was 10 and 9 years among patients in the
DCM and RC arms respectively, therefore, longer dur-
ation might have resulted in no significant improvement
in HbA1c during the 3 months duration after enroll-
ment. Future studies with longer duration of follow-up
after the intervention are recommended to evaluate the
impact of DCM on HbA1c.
In this study, we also found significant improvement
in the scores based on DMSE sub-scales for example, 1)
exercise and weight control, 2) health seeking and dia-
betes treatment, 3) blood sugar monitoring, and 4) diet
control. This has important implications for decreasing
the treatment non-compliance, lack of responsibility for
self-care, dietary control, health seeking behavior and
weight management [21].
Important limitations should be considered before
drawing any conclusion based on this study. First, this
trial was conducted only in one public sector tertiary
care hospital in Karachi and generalizability to other set-
tings might be limited. Second, our follow-up of 3
months after enrollment might not be sufficient to
measure a change in the clinical outcome e.g. HbA1c.
However, these patients are regularly visiting the given
hospital and their HbA1c levels are routinely measured.
The HbA1c data on 6months and 9months following
recruitment in the study can be retrieved subject to the
approval of the revised ethical application. On the other
hand, one of the important strengths of this study is
100% retention of the participants during the follow-up
period. The higher retention was possible due to excel-
lent rapport between the study participants and the
study staff, phone call reminders at least 1 day before
the scheduled visit and better time management during
the sessions (no waiting time and finishing sessions on
time). Besides, validated tools in local language for the
assessment of DMSE was used.
Conclusions
DCM performed better as compared to the routine care
in improving DMSE among patients with type 2 diabetes
in a developing country like Pakistan. Clinicians and
nurses dealing with diabetic patients are recommended
to use DCM rather than routine counselling methods
for the education of their patients especially in develop-
ing countries.
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